AEON Biopharma (AEON) Non-Current Debt (2022 - 2026)
AEON Biopharma (AEON) posted Non-Current Debt of $34.6 million for Q4 2025, up 102.92% sequentially from $17.1 million in Q3 2025, and up 196.0% YoY from $11.7 million in Q4 2024.
AEON Biopharma (AEON) Non-Current Debt (2022 - 2026) Analysis & Trends
AEON Biopharma has reported Non-Current Debt for 3 years, with the latest figure at $34.6 million in Q4 2025.
- Quarterly Non-Current Debt rose 196.0% year-over-year to $34.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.6 million (up 196.0% YoY) and the FY2025 annual result came in at $34.6 million, up 196.0% from the prior year.
- Non-Current Debt rose to $34.6 million in Q4 2025 per AEON's latest filing, from $17.1 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $34.6 million in Q4 2025 and troughed at $5.1 million in Q1 2024.
- A 3-year average of $16.5 million and a median of $15.2 million in 2024 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 196.0% in 2025, down 12.4% in 2025.
- Over 3 years, Non-Current Debt stood at $23.1 million in 2022, then slumped by 49.47% to $11.7 million in 2024, then jumped by 196.0% to $34.6 million in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $34.6 million, $17.1 million, and $15.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 34.60 Mn |
| Sep 30, 2025 | 17.05 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 13.32 Mn |
| Dec 31, 2024 | 11.69 Mn |
| Sep 30, 2024 | 15.17 Mn |
| Jun 30, 2024 | 13.29 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Dec 31, 2022 | 23.13 Mn |